SynBiotic SE (ETR:SBX)
Germany · Delayed Price · Currency is EUR 0.9510
-0.0490 (-4.90%)
Sep 4, 2026, 4:50 PM CET
SynBiotic SE Market Cap
SynBiotic SE has a market cap or net worth of €6.82 million as of September 4, 2026. Its market cap has decreased by -67.57% in one year.
Market Cap
6.82M
Enterprise Value
6.92M
Revenue
14.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.95
ChartMarket Cap Chart
Since January 7, 2021, SynBiotic SE's market cap has decreased from 49.05M to 6.82M, a decrease of -86.09%. That is a compound annual growth rate of -29.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 6.82M | -64.54% |
| Dec 30, 2025 | 19.24M | -32.82% |
| Dec 30, 2024 | 28.64M | 107.48% |
| Dec 29, 2023 | 13.81M | -64.07% |
| Dec 30, 2022 | 38.43M | -60.60% |
| Dec 30, 2021 | 97.53M | 98.83% |
| Jan 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 60.76B |
| Bayer Aktiengesellschaft | 48.02B |
| Siemens Healthineers AG | 43.74B |
| Fresenius SE & Co. KGaA | 25.22B |
| aap Implantate AG | 22.26M |
| NanoRepro AG | 21.95M |
| Maternus-Kliniken Aktiengesellschaft | 18.35M |
| Biofrontera AG | 14.58M |